The beverage tea in chemoprevention of prostate cancer

Mohammad Saleem, Imtiaz Ahmad Siddiqui, Hasan Mukhtar

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations


In recent years, many laboratories around the world have reported several health-beneficial, especially cancer-preventive, effects of tea consumption in animal models and human population studies. We reasoned that prostate cancer represents an ideal candidate disease for chemoprevention because even a modest delay achieved through intervention through drugs or diet could have a significant impact on the outcome of this disease. Based on the epidemiological studies and recent data, amassed from various laboratories around the world, there is convincing evidence that polyphenolic antioxidants present in the beverage tea, such as epigallocatechin-3-gallate (EGCG), epigallocatechin (EGC) and epicatechin-3-gallate (ECG), may have the potential to lower the risk of prostate cancer in the human population. Our recent study has demonstrated that green tea polyphenols, when given to transgenic adenocarcinoma of the mouse prostate (TRAMP), a transgenic mouse model that mimics progressive forms of human prostate cancer, exerts remarkable preventive effects against prostate cancer development. The results from a recent human study conducted in China have demonstrated that the prostate cancer risk declined with increasing frequency, duration and quantity of green tea consumption. This chapter addresses the issue of possible use of tea beverage, especially green tea, for the chemoprevention of prostate cancer.

Original languageEnglish (US)
Title of host publicationProtective Effects of Tea on Human Health
PublisherCABI Publishing
Number of pages11
ISBN (Print)1845931122, 9781845931124
StatePublished - Sep 29 2006
Externally publishedYes


Dive into the research topics of 'The beverage tea in chemoprevention of prostate cancer'. Together they form a unique fingerprint.

Cite this